HGH Therapy and Visceral Fat: What the Research Really Shows

One of the most common reasons adults seek HGH therapy is stubborn abdominal fat that resists diet and exercise. This visceral fat is metabolically active and linked to elevated cardiovascular risk, insulin resistance, and inflammation. So what does the research actually say?

HGH Therapy and Visceral Fat

Why Adults with Growth Hormone Deficiency Accumulate Visceral Fat

Adult growth hormone deficiency (AGHD) is closely associated with increased visceral adiposity. Growth hormone plays a key role in regulating fat breakdown, or lipolysis, particularly in abdominal fat cells that are especially sensitive to GH signaling. When growth hormone declines, the body shifts toward fat storage — especially viscerally — resulting in increased total body fat, a disproportionate accumulation of visceral fat, reduced lean muscle mass, and an unfavorable lipid profile.

What the Research Shows

Multiple peer-reviewed studies show that HGH therapy can reduce visceral fat in adults with confirmed growth hormone deficiency, although the magnitude and timing vary by population and protocol. A randomized, placebo-controlled study in women with GH deficiency found that low-dose GH replacement decreased visceral adipose tissue by about 9% compared with placebo and improved cardiovascular risk markers. A meta-analysis of recombinant human growth hormone in adults reported a weighted mean reduction in visceral adipose area of about 22.8 cm² versus placebo, along with decreases in total fat mass and LDL cholesterol.

How Long Does It Take to See Results?

Body composition changes from HGH therapy are gradual and cumulative rather than immediate. Many patients begin noticing changes in fat distribution and lean mass within three to six months, while stronger visceral-fat effects are often seen after twelve months or more of consistent, monitored treatment. HGH therapy is not a rapid fat-loss intervention — it works by restoring hormonal balance so metabolism can function more efficiently over time.

Realistic Expectations

The strongest evidence applies to adults with documented growth hormone deficiency confirmed through baseline IGF-1 testing and clinical evaluation. Using growth hormone without a confirmed deficiency is supported by a weaker and more mixed evidence base, and it also carries metabolic considerations such as modest increases in fasting glucose in some studies. For a neutral medical overview of adult growth hormone deficiency, see the MedlinePlus overview.

Synergya Medical’s Body Composition Approach

At Synergya Medical, our A4M-certified physicians confirm the clinical indication, establish a safe starting dose, and monitor your progress with regular labs and physician follow-up. We understand you want to feel stronger, look better, and carry less abdominal fat, which is why our treatment plans are individualized rather than one-size-fits-all. If you want to learn whether therapy may be right for you, review our page on HGH therapy or contact our team for a consultation.
“Once I understood how HGH therapy actually works, my perspective changed. I had always assumed it was “only for bodybuilders,” so I never considered myself a candidate. After my doctor walked me through the symptoms, lab work, and safety checks, it stopped being about whether I wanted HGH and became a straightforward question: do I genuinely meet the medical criteria for treatment?” — Patient perspective